Latest Biotech News

Swiss biotech 4bases and the University of Florence began clinical pilot studies validating nanopore sequencing for copy‑number variant detection in two Italian hospitals using the KaryoSolver...

Genomics pioneer J. Craig Venter launched Diploid Genomics, an AI‑driven advanced genomics analytics company, with Healthier Capital as a cofounder and sole external investor. The new company...

Large drugmakers moved this month to deploy AI as an enterprise discovery engine, signing multi-target platform agreements with AI startups. Eli Lilly, GSK and Pfizer each struck deals to...

The US Food and Drug Administration issued draft guidance endorsing measurable residual disease (MRD) and complete response as potential endpoints to support accelerated approval pathways in...

Corcept Therapeutics reported phase 3 results showing relacorilant, an oral selective glucocorticoid receptor antagonist, reduced risk of death by 35% in platinum‑resistant ovarian cancer in the...

Bristol Myers Squibb signed an exclusive collaboration and license with Janux Therapeutics to develop tumor‑activated T‑cell engagers, providing $50 million upfront and up to $800+ million in...

Corxel Pharmaceuticals closed a $287 million financing to advance its oral GLP‑1 candidate into phase 2/3 studies. The company licensed the oral agent from China‑based Vincentage in 2024 and is...

Genomics pioneer J. Craig Venter co‑founded Diploid Genomics, Inc., unveiling an AI‑driven analytics company backed by Healthier Capital as sole external investor. The new firm will develop...

A provision in the current appropriations bill would allow Medicare to cover multi‑cancer early detection (MCED) tests after FDA approval without awaiting US Preventive Services Task Force...

The National Institutes of Health announced it will end support for research using human fetal tissue, a decision that several scientists called political rather than scientific. The move affects...

Swiss company 4bases and the University of Florence launched clinical pilot studies of a nanopore sequencing‑based cytogenetics workflow, KaryoSolver, in two Italian hospitals. The pilots aim to...

Researchers unveiled camouflaged nanorobots engineered to modulate macrophage behavior within neural tissue and promote regeneration. The devices are designed to influence immune cell polarization...

The FDA approved Guardant Health’s Guardant360 CDx as a companion diagnostic to identify BRAF V600E–mutant metastatic colorectal cancer patients for Pfizer’s encorafenib (Braftovi) plus cetuximab...

Regulators signaled a new pathway for multiple myeloma drug development by issuing draft guidance that permits measurable residual disease (MRD) negativity and complete response rates to support...

Corcept Therapeutics reported a 35% reduction in risk of death when its selective glucocorticoid receptor antagonist relacorilant was added to chemotherapy in platinum‑resistant ovarian cancer,...

Bristol Myers Squibb struck a two-stage collaboration with Janux Therapeutics to develop tumor‑activated (masked) T‑cell engagers, providing $50 million upfront and potential payments pushing the...

Major pharma companies moved from one‑off asset partnerships to platform investments, signing AI platform deals with startups like Chai Discovery, Noetik and Boltz to deploy models for biologics...

Corxel Pharmaceuticals closed a $287 million financing to support global development of its oral GLP‑1 candidate, a program the company licensed from Vincentage. The round funds pivotal phase 2/3...

Swiss firm 4bases began clinical pilot studies in two Italian hospitals to validate a nanopore sequencing workflow, KaryoSolver, for real‑time detection of copy number variants (CNVs) against...

Avacta Therapeutics received FDA IND clearance for AVA‑6103, a tumor‑activated precision peptide‑drug conjugate targeting FAP, clearing the way for first‑in‑human studies in solid tumors....